Typhoid-Paratyphoid Vaccines
Sponsors
Finlay Institute
Conditions
typhoid fever
Phase 2
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.
Active, not recruitingRPCEC00000056
Start: 2002-01-09Updated: 2026-09-14
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.
Active, not recruitingRPCEC00000055
Start: 2002-02-12Updated: 2026-09-14